Oncopeptides AB: Oncopeptides Chief Financial Officer Holger

STOCKHOLM, Jan. 18, 2023 /PRNewswire/ -- Oncopeptides AB (publ.) (NASDAQ Stockholm: ONCO), a biotech company focused on commercialization, research, and development of therapies for difficult-to-treat

Related Keywords

Norway , Iceland , Liechtenstein , Stockholm , Sweden , United Kingdom , Lichtenstein , Monica Shaw , Holger Lembrer , Rolf Gulliksen , Leadership Team , European Union , Global Head Of Corporate Communications , Nasdaq , Chief Financial Officer , Global Head , Corporate Communications , Peptide Drug Candidate , Marketing Authorization , Small Cap , Chief Financial Officer Holger Lembrer , Oncopeptides , Chief , Financial , Officer , Holger , Embrer , Akes , Office , Oday ,